A nurse is caring for a client who had an inferior vena cava (IVC) filter inserted. Which intervention should the nurse include in the client's post-procedural plan of care?

Monitoring the insertion site for bleeding or hematoma is the priority nursing intervention after IVC filter insertion to detect complications early. Other options may increase bleeding risk or are not immediate priorities.

Post-Procedural Care After IVC Filter Insertion

The correct intervention to include in the plan of care is to monitor the insertion site for signs of bleeding or hematoma. An inferior vena cava (IVC) filter is placed via a percutaneous approach, most commonly through the femoral or internal jugular vein. This process involves accessing a large central vein with a sizable introducer sheath, which creates a direct tract through the vessel wall. The immediate post-procedural period carries a risk of vascular access site complications, primarily bleeding and hematoma formation, because the venous puncture site has not yet achieved stable hemostasis.

The foundational principle of post-procedural care for any percutaneous vascular access is vigilant assessment for hemorrhagic complications. While the provided source materials focus on arterial access closure in transfemoral transcatheter aortic valve replacement (TF-TAVR) and peripheral endovascular procedures, the physiological principle of vessel wall healing and the risk profile of a large-bore venous access site are directly analogous. A study on femoral arteriotomy closure after peripheral endovascular procedures highlights that a composite of access-site complications, including hematoma, pseudoaneurysm, and bleeding requiring intervention, is a primary endpoint when evaluating hemostatic strategies . This underscores that even with meticulous technique, the insertion site remains a critical point of surveillance. For an IVC filter, the nurse must perform serial assessments of the dressing site, noting any active bleeding, oozing, or expanding ecchymosis, and palpate for a firm, tender swelling that would indicate a developing hematoma. This monitoring is essential because a venous hematoma can dissect into the retroperitoneal space, especially with a femoral approach, leading to significant, concealed blood loss.

The other options are not appropriate for immediate post-IVC filter care. Encouraging early ambulation within 2 hours is contraindicated. The large venous access site requires a period of immobility and direct pressure to allow a stable clot to form at the puncture site. Early movement would disrupt this nascent clot and dramatically increase the risk of bleeding. Applying heat to the insertion site is also incorrect; heat promotes vasodilation and increased blood flow, which would counteract the vasoconstriction and platelet plug formation necessary for hemostasis. The standard of care is to apply direct manual pressure or a pressure dressing. Finally, the decision to administer anticoagulants is not an automatic, immediate post-procedure order. While many patients with an IVC filter have a contraindication to anticoagulation, if the contraindication resolves, the therapeutic plan is determined by the provider. Anticoagulation is not initiated immediately after the procedure due to the active risk of bleeding from the fresh access site; a safe window of hemostasis must be established first. The technical reports on IVC filter retrieval further emphasize the complexity of these devices and the venous system, noting that complications like iliocaval thrombosis are managed with a combination of endovascular techniques and subsequent anticoagulation, but this is a separate, non-immediate clinical decision .